FAQ
In June 2021, the U.S. Food and Drug Administration (FDA) approved branded medications containing semaglutide as the active ingredient, including Wegovy®, Ozempic®, and Rybelsus®. These medications are FDA-approved for specific uses such as type 2 diabetes and chronic weight management.
At our clinic, we do not dispense these FDA-approved brands. Instead, we provide a compounded version of semaglutide. This version is prepared by a licensed 503A compounding pharmacy and is not approved by the FDA. However, it may be legally prescribed by a licensed healthcare provider when it is determined to be medically appropriate and when FDA-approved alternatives are not suitable or available.
Although compounded semaglutide is based on the same active ingredient, it has not undergone FDA review for safety, efficacy, or quality in the same way as commercial brand-name products.
Patients with the following conditions should not take semaglutide:
- diabetic retinopathy, a type of damage to the eye from diabetes
- low blood sugar
- disease of the gallbladder
- decreased kidney function
- pancreatitis
- medullary thyroid cancer
- multiple endocrine neoplasia type 2
- family history of medullary thyroid carcinoma
- kidney disease with likely reduction in kidney function
- pregnant or plan to become pregnant, breastfeeding or plan to breastfeed
Clinical studies of FDA-approved semaglutide products (such as Wegovy®) showed an average weight loss of up to 15% of initial body weight when combined with diet and lifestyle changes.
Our clinic offers a compounded version of semaglutide, which is not FDA-approved but may be legally prescribed by a licensed provider. Results may vary, and weight loss depends on multiple factors including individual metabolism, adherence to the treatment plan, and lifestyle choices.
Semaglutide is available in both pill and injectable forms.
However, at our clinic, we provide a compounded version of semaglutide as a once-weekly injection, prepared by a licensed 503A compounding pharmacy. This formulation is not FDA-approved but may be prescribed by a licensed provider when appropriate.
Storage Instructions for Compounded Semaglutide
Semaglutide must be refrigerated at all times when not in use (between 36°F and 46°F / 2°C and 8°C).
Once the vial has been punctured by a needle, it should be used within 30 days and must remain refrigerated during that time.
Do not freeze. Discard any unused medication after 30 days from first use.
Once enrolled and approved we place your prescription with our partnered 503b pharmacy within 2 business days. Once the pharmacy receives the order they will fill the prescription within 3 to 5 business days. Semaglutide/Cyanocobalamin is shippd overnight in a cold packed package.
You can find our Payment, Delivery, and Refund Policy at the following links: Payment,
Nevada
